SEARCH

PTAB.US: Decisions of PTAB Patent Trial and Appeal Board

Monday, April 12, 2010

fisher,

REVERSED 
1600 Biotechnology and Organic Chemistry 
Ex Parte Nezu et al 10/762,154 WALSH 101/112(1) FISH & RICHARDSON PC
[A]n application must show that an invention is useful to the public as disclosed in its current form, not that it may prove useful at some future date after further research. Simply put, to satisfy the “substantial” utility requirement, an asserted use must show that that claimed invention has a significant and presently available benefit to the public. . . . in addition to providing a “substantial” utility, an asserted use must also show that the claimed invention can be used to provide a well-defined and particular benefit to the public.
In re Fisher, 421 F.3d 1365, 1371 (Fed. Cir. 2005). “It is well established that the enablement requirement of § 112 incorporates the utility requirement of § 101.” Fisher, 421 F. 3d at 1378

Fisher, In re, 421 F.3d 1365, 76 USPQ2d1225 (Fed. Cir. 2005) . . . .. . . . . . . .2106, 2107.01 
 
Ex Parte Schmid-Schonbein et al 11/850,169 PRATS 102(b)/103(a)/101 37 C.F.R. § 41.50(b) FISH & ASSOCIATES, PC 

AFFIRMED-IN-PART 
1700 Chemical & Materials Engineering 
Ex Parte Chen 11/084,571 KIMLIN 103(a) HEWLETT-PACKARD COMPANY 

3700 Mechanical Engineering, Manufacturing, and Products & Design 

Ex Parte Ihde 10/714,200 PATE III 112(1)/102(b)/103(a) HUSCH BLACKWELL SANDERS LLP